These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16967707)

  • 21. The role of medicinal chemistry in treating obesity, diabetes and metabolic syndrome.
    Ortúzar N
    ChemMedChem; 2013 Apr; 8(4):535-7. PubMed ID: 23529925
    [No Abstract]   [Full Text] [Related]  

  • 22. Type 2 diabetes epidemic increases use of oral anti-diabetic agents.
    Capriotti T
    Medsurg Nurs; 2005 Oct; 14(5):341-7. PubMed ID: 16318117
    [No Abstract]   [Full Text] [Related]  

  • 23. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic diseases.
    Balfe A; Perry L
    IDrugs; 2006 Nov; 9(11):754-5. PubMed ID: 17096291
    [No Abstract]   [Full Text] [Related]  

  • 25. [Night-time hypoglycemia in patients with type 2 diabetes].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Jun; 151(26-29):40-1. PubMed ID: 19739548
    [No Abstract]   [Full Text] [Related]  

  • 26. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome.
    Jetté L; Harvey L; Eugeni K; Levens N
    Curr Opin Investig Drugs; 2009 Apr; 10(4):353-8. PubMed ID: 19337956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic options for modifying cardiometabolic risk factors.
    Aronne LJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversing the tide of metabolic syndrome.
    Dumas MA
    Nurs Manage; 2003 Jun; 34 Suppl Guide():1-5. PubMed ID: 12867772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
    [No Abstract]   [Full Text] [Related]  

  • 31. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm.
    Green J; Feinglos M
    Int J Clin Pract Suppl; 2007 Aug; (154):3-11. PubMed ID: 17593272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.
    Saxon DR; Rasouli N; Eckel RH
    Drugs; 2018 Feb; 78(2):203-214. PubMed ID: 29305768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the discovery of 11beta-HSD1 inhibitors.
    Boyle CD
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):495-511. PubMed ID: 18600567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
    Isaacsohn JL; Troendle AJ; Orloff DG
    Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and obesity: the twin epidemics.
    Smyth S; Heron A
    Nat Med; 2006 Jan; 12(1):75-80. PubMed ID: 16397575
    [No Abstract]   [Full Text] [Related]  

  • 38. [Basic concept for the treatment of metabolic syndrome].
    Katayama S
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():566-70. PubMed ID: 21766661
    [No Abstract]   [Full Text] [Related]  

  • 39. [Discharge letter with therapeutic recommendations: you have to sort out!].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Mar; 152(10):31-2. PubMed ID: 20380229
    [No Abstract]   [Full Text] [Related]  

  • 40. [Optimal therapeutic strategy in type 2 diabetes mellitus].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.